Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Wealth
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    ;
    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Finance

    Strong Chinese demand helps Danone to beat sales forecasts

    Strong Chinese demand helps Danone to beat sales forecasts

    Published by Global Banking and Finance Review

    Posted on April 23, 2025

    Featured image for article about Finance

    By Dominique Vidalon

    PARIS (Reuters) -Danone beat first-quarter sales expectations on Wednesday, as strong demand in China for infant milk formula and medical nutrition products outpaced weakness in coffee creamers in a competitive U.S. market.

    The French consumer goods group, whose brands include Evian and Badoit water and Activia yoghurt, said first-quarter sales rose 4.3% on a like-for-like basis, compared with expectations of 3.8% in a company-provided analysts' consensus.

    "With a 4.3% like-for-like sales growth in Q1, we have delivered a strong start to the year, across all categories, demonstrating the strength of our execution and the relevance of our health-focused portfolio," CEO Antoine de Saint-Affrique said in a statement.

    The company's shares opened down 0.5%.

    Danone posted a "solid set of numbers", said Bernstein analysts in a note, defying recent fears after some data had pointed to slowing growth.

    The analysts also highlighted the 2.4% contribution from prices, up from 0.6% last quarter, which would help profits this year at a time of higher dairy costs.

    Sales for the three months ended March 31 totalled 6.844 billion euros ($7.79 billion).

    Danone's growing focus on health and science makes it more resilient in an environment marked by U.S. tariff uncertainty and weak consumer sentiment, De Saint-Affrique said.

    China was the "star performer", said analysts at Barclays, with Danone gaining market share in infant formula, helped by its premium Essensis product. It is also seeing strong demand for medical nutrition products and the Mizone water drink.

    Sales in North America, meanwhile, were up 3.7% in the quarter, driven by demand for protein products such as the Oikos brand Greek yoghurt range, which helped offset a "soft start" from coffee creamers in the United States.

    Danone also faced supply chain issues in the first quarter that were now solved, finance chief Juergen Esser told reporters.

    The company reiterated its full year 2025 forecast was in line with its mid-term ambition of like-for-like sales growth of between 3% and 5%, with recurring operating income growing faster than sales.

    ($1 = 0.8783 euros)

    (Reporting by Dominique Vidalon;Editing by Sudip Kar-Gupta, Dominique Patton and Jane Merriman)

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe